Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 296, pseudogene (RNU6-296P) is classified as a **pseudogene** derived from U6 small nuclear RNA (snRNA) sequences[1][6]. U6 snRNAs are essential components of the spliceosome, the cellular machinery responsible for removal of introns from pre-mRNA during mRNA splicing[3][5]. However, RNU6-296P lacks protein-coding capability and does not produce a functional RNA product; it bears sequence similarity to authentic U6 snRNA genes but contains structural differences such as direct sequence repeats, reflecting its origin as a nonfunctional genomic copy[2]. There are many U6-derived pseudogenes in the human genome, which are considered "genomic fossils" without canonical regulatory or enzymatic activity[5][2]. No evidence exists for a physiological, pathological, or therapeutic role of RNU6-296P. **Key Points:** - RNU6-296P is a **pseudogene** and not an active molecular target, enzyme, transporter, or receptor. - It is not implicated in biological processes, disease roles, or therapeutic mechanisms. - No drugs, disease associations, mechanisms of action, biomarkers, or safety concerns are reported for this pseudogene. - Its sequence reflects evolutionary remnants of the essential U6 snRNA gene, central in spliceosome function, but **RNU6-296P itself is nonfunctional**[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 296, pseudogene (RNU6-296P).